Qiuxia
Qiuxia Hu, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20130036780 | MAGNETICALLY RELEASABLE SECURITY TAG - A security tag is provided that includes a housing, an electronic sensor held within the housing, an accessory pin provided with the housing and a lock assembly held within the housing. The accessory is pin provided with the tag housing and may be moveable with respect to the housing between locked and unlocked positions. When the accessory pin is in the locked position, the tag housing is secured to the accessory. When the accessory pin is in the unlocked position, the tag housing is disengaged from the accessory. The lock assembly may include a magnetically influenced (MI) member which is movable from a biased position to a relaxed position in the absence of the selected magnetic field to lock the accessory pins. | 02-14-2013 |
Qiuxia Wang, Somerville, NJ US
Patent application number | Description | Published |
---|---|---|
20100216886 | POLYMORPHS OF N2-(1,1'-BIPHENYL-4-YLCARBONYL)-N1-[2-(4-FLUOROPHENYL)-1,1-DIMETHYLETHYL]- -L-ALPHA-GLUTAMINE - Disclosed are novel polymorphic forms of N | 08-26-2010 |
Qiuxia Xu, Chaoyang District CN
Patent application number | Description | Published |
---|---|---|
20130037822 | Semiconductor Device and Manufacturing Method Thereof - A semiconductor device and its manufacturing method are provided. The semiconductor device comprises: a semiconductor substrate of a first semiconductor material, a gate structure on the semiconductor substrate, a crystal lattice dislocation line in a channel under the gate structure for generating channel stress, wherein the crystal lattice dislocation line being at an angle to the channel. | 02-14-2013 |
Qiuxia Yang, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20110077291 | Preparations of Taxanes for Intravenous Administration and the Preparation Method Thereof - The present invention relates to the field of medical technology. More specifically, the present invention relates to a preparation of taxanes for intravenous administration, which consists of two parts: a drug solution and an emulsion. Said drug solution consists of paclitaxel or docetaxel, a pH regulator and a solvent for injection, wherein said solvent for injection is an organic solvent. Said emulsion includes a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When used, the drug solution at the clinical dosage can be added and mixed homogeneously in the emulsion to perform intravenous drip directly; or the drug solution at the clinical dosage can also be firstly added into the emulsion with no less than 5 times volume of the drug solution and then a predetermined amount of normal saline or glucose solution for injection is added to perform intravenous drip. The preparation of the present invention does not contain solubilizer and has advantages of little toxicity, safety, effectiveness, stability and economy. The fat emulsion is also used as a nutritional replenishment, thus achieving a better therapeutic effect. In addition, the normal saline or glucose solution for injection can be used to replace a considerable amount of the emulsion, which makes the preparation, therefore, not only cost-efficient, but also convenient for transportation and storage in practice. | 03-31-2011 |
Qiuxia Yang, Tianjin CN
Patent application number | Description | Published |
---|---|---|
20120157517 | PHARMACEUTICAL SOLUTION OF TAXANES COMPRISING PH REGULATOR AND PREPARATION METHOD THEREOF - A pharmaceutical solution of taxanes, its preparation method, a composition comprising said solution and its pharmaceutical combination package are disclosed. Said pharmaceutical solution comprises taxanes, a pH regulator and a solvent, wherein the pH regulator is a water-soluble acid. | 06-21-2012 |
20140045927 | PREPARATIONS OF TAXANES FOR INTRAVENOUS ADMINISTRATION AND THE PREPARATION METHOD THEREOF - The present invention relates to the field of medical technology. More specifically, the present invention relates to a preparation of taxanes for intravenous administration, which consists of two parts: a drug solution and an emulsion. Said drug solution consists of paclitaxel or docetaxel, a pH regulator and a solvent for injection, wherein said solvent for injection is an organic solvent. Said emulsion includes a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When used, the drug solution at the clinical dosage can be added and mixed homogeneously in the emulsion to perform intravenous drip directly; or the drug solution at the clinical dosage can also be firstly added into the emulsion with no less than 5 times volume of the drug solution and then a predetermined amount of normal saline or glucose solution for injection is added to perform intravenous drip. The preparation of the present invention does not contain solubilizer and has advantages of little toxicity, safety, effectiveness, stability and economy. The fat emulsion is also used as a nutritional replenishment, thus achieving a better therapeutic effect. In addition, the normal saline or glucose solution for injection can be used to replace a considerable amount of the emulsion, which makes the preparation, therefore, not only cost-efficient, but also convenient for transportation and storage in practice. | 02-13-2014 |
Qiuxia Zhang, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20090270910 | Method and Apparatus for Increasing Blood Flow in a Body Part - An enclosure is dimensioned to enclose an affected area of a body part plus a small margin around which a releasable seal is attached to make the enclosure substantially airtight around the body part without contacting the area to be treated. A port in the enclosure is attached to tubing for connection of a pump for forcing air under pressure into the enclosure. In the preferred embodiment, the enclosure is an inflatable plastic bag. The compression provided by the air pressure is applied uniformly to the body part to increase blood flow within the body part without physically contacting the affected area of the body part. In one embodiment, the pump is a combination air and vacuum pump so that pressures within the enclosure may be cycled between high and low pressures. | 10-29-2009 |